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Abstract 
Under stress, metabolism is changing: specific up- or down-regulation of proteins and 
metabolites occurs as well as side-effects. Distinguishing specific stress-signaling metabolites 
(alarmones) from side-products (damage metabolites) is not trivial. One example is 
diadenosine tetraphosphate, Ap4A – a side-product of aminoacyl-tRNA synthetases found in 
all domains of life. The earliest observations suggested that Ap4A serves as an alarmone for 
heat stress in E. coli. However, despite 50 years of research, the signaling mechanisms 
associated with Ap4A remain unknown. We defined a set of criteria for distinguishing 
alarmones from damage metabolites to systematically classify Ap4A. In a nutshell, no 
indications for a signaling cascade that is triggered by Ap4A were found; rather, we found 
that Ap4A is efficiently removed in a constitutive, non-regulated manner. Several-fold 
perturbations in Ap4A concentrations have no effect, yet accumulation at very high levels is 
toxic due to disturbance of zinc homeostasis, and also because Ap4A’s structural overlap 
with ATP can result in spurious binding and inactivation of ATP binding proteins. Overall, 
Ap4A met all criteria for a damage metabolite. While we do not exclude any role in 
signaling, our results indicate that the damage metabolite option should be considered as the 
null hypothesis when examining Ap4A and other metabolites whose levels change upon 
stress.  
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Introduction 
Metabolites are small, natural organic molecules. The vast majority of metabolites take part 
in catabolic and anabolic reactions, while others serve to initiate signaling cascades, as 
secondary messengers, including alarmones. In bacteria, alarmone production is induced 
during stress (e.g., starvation, heat, oxidative stress) and their presence activates adequate 
cellular responses [1,2]. In most cases, secondary messengers comprise specific metabolites 
with no additional roles. However, metabolites with dual roles are also known, including 
NAD – an essential enzymatic cofactor that also acts as a signaling molecule in regulating 
transcription, apoptosis and DNA repair [3]. In recent years, another class of metabolites, 
damage metabolites, has attracted considerable attention
 
[4,5]. Damage metabolites are side-
products of enzymatic reactions, or products of non-enzymatic breakdown of other 
metabolites. Their accumulation can be deleterious, and thus, enzymatic pathways that 
convert them into harmless products have evolved. Under stress, damage metabolites may 
accumulate more rapidly, and their effects on cell growth and viability may become 
pronounced [6]. However, not every side-product is a damage metabolite, and not every 
metabolite whose concentration rises under stress is an alarmone. Distinguishing between 
side-effects and specifically induced effects of stress is not trivial. For example, increased 
mutation rates under stress  have been proposed to be adaptive [7], but high mutation rates 
can also be a mere side-effect of stress [8].  
Diadenosine tetraphosphate (Ap4A) is the example of a metabolite that could belong to either 
category – damage metabolite, or alarmone. Discovered 50 years ago [9], this molecule 
remains a mystery. Ap4A is generated as a side-product of aminoacyl-tRNA synthetases 
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(AARS) [10], by ATP reacting with the amino-acid-AMP intermediate, or directly, via 
reaction of two ATPs [11]. During normal growth, in vivo concentrations of Ap4A seem to 
vary widely from 0.05-1 µM in mammalian cells [12] to 1-3 µM in bacteria [13]. These 
relatively low concentrations (< 103-fold lower than ATP) are the outcome of Ap4A 
hydrolases, and/or Ap4A phosphorylases (where phosphate acts as nucleophile instead of 
water), seen in all kingdoms of life. In E. coli, Ap4A concentrations were reported to respond 
to external stimuli such as heat [14], oxidative stress [15,16], and ethanol [17]. These 
observations led to the hypothesis that Ap4A functions as an alarmone [15,18]. Throughout 
the years, Ap4A has been linked to a wide range of key biological functions ranging from 
heat-stress response in E. coli [14] to mammalian tear secretion [19] and is described in > 500 
research reports. However, to date, no signaling pathways that are specifically triggered by 
Ap4A are known, certainly not in bacteria. On the other hand, knockout of Ap4A hydrolase 
(ApaH) results in high Ap4A levels, increased sensitivity to heat and starvation [20], 
weakened stress-induced mutagenesis response [21], decreased persister formation [22] and 
inhibit sporulation [16]. 
Two hypotheses should be therefore considered: (i) Ap4A is an alarmone with specific 
signaling and/or regulatory roles in stress, or (ii) Ap4A is a damage metabolite. These 
hypotheses are not necessarily mutually exclusive – Ap4A may have emerged as damage 
metabolite, and mechanisms for its removal have consequently evolved, but it may had also 
been recruited in some organisms for specific signaling. To assign Ap4A, or any metabolite, 
to one category or another, it is necessary to establish specific criteria. 
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An alarmone and/or a secondary messenger should meet the following criteria: 
1. Alarmone levels must be regulated such that basal levels persist during ambient 
conditions and a transient concentration change is triggered by stress [23].  
2. An increase in concentration under stress is not indicative in itself. Rather, 
alarmone levels are controlled via production and/or degradation, whereby the 
corresponding enzymes are regulated, transcriptionally and/or at the protein level, 
in response to specific triggers [24,25].  
3. Alarmone production and/or degradation via an artificially regulated enzyme 
would affect growth, under normal conditions and/or stress [26–28]. 
4. Transcription factors or allosteric enzymes are found that are selectively 
modulated by the alarmone. These regulated proteins would be associated with 
other proteins whose levels change when alarmone levels change (e.g. via 
transcriptional regulation networks) [29].  
Not all criteria must be fulfilled. For example, changes in NAD levels are not induced as 
such, but they are sensed and can initiate a signaling cascade. Thus, while criterion 1 is 
irrelevant for NAD, criterion 4 has been met [30].  
On the other hand, distinct criteria of damage metabolites include: 
5. It is a side-product of a metabolic enzyme rather than being produced by a 
dedicated enzyme that is accordingly regulated [31]. 
6. Enzyme(s) that degrade damage metabolites exist and degradation is 
constitutive rather then regulated [32].  
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7. The damage metabolite can accumulate to some degree with no physiological 
effects yet become toxic upon exceeding a certain threshold, especially under 
stress. Accordingly, removal of a damage-metabolite degrading enzyme(s) is 
deleterious but not lethal [33].  
We attempted to systematically examine these criteria, using E. coli as a case study. We 
found that Ap4A is constitutively removed - its degradation is not regulated, neither 
transcriptionally nor at the enzyme level (criteria 1 and 2 not met). Artificially induced 
production, or complete degradation of the Ap4A, had no growth effect (criteria 3 not met) 
and proteins that sense and respond to change in Ap4A cellular level were not identified 
(criteria 4 not met). On the other hand, Ap4A is a side-product of essential, metabolic 
enzymes, and its homeostasis is maintained by a constitutively expressed Ap4A hydrolase 
(criteria 5 and 6 fulfilled). Ap4A becomes toxic but not lethal, only when its concentration 
rises dramatically, and even then, only under stress conditions (criterion 7 fulfilled). Overall, 
Ap4A does not fit any of the alarmone criteria, while all damage metabolite criteria are 
fulfilled. The criteria and tools developed here, foremost, the laboratory sub-functionalization 
of E. coli’s lysyl tRNA-synthetase (LysRS) to generate an Ap4A synthetase - can be applied 
to decipher the role of Ap4A, and of other stress-related metabolites, in other organisms. 
 
Results 
Ap4A hydrolase (ApaH) deficient strains 
The only currently available way of perturbing Ap4A levels has been via knockout of E. 
coli’s Ap4A hydrolase (ApaH), a symmetrical hydrolase which generates two ADP 
molecules and belongs to the Nudix superfamily [34,35]. Several phenotypes associated with 
the apaH knockout have been reported, but their mechanistic basis remains unknown. 
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Specifically, the apaH knockout was reported to have intracellular Ap4A levels that are 
~100-fold higher than wild-type and increased sensitivity to stress [20–22].  
We constructed a series of apaH genetic constructs, aiming to ensure that the observed 
ΔapaH phenotypes are a direct outcome of increased Ap4A concentration and not due to 
other, unknown secondary functions of ApaH (Table 1). The level of Ap4A in the ΔapaH 
strain, measured by LC-MS, during growth in minimal medium (M9 with 0.4 % glucose; M9-
Glc) increased ~350-fold, from 0.2 µM in wild-type to 65 µM in ΔapaH (Table 1). In rich 
media, the E. coli K12 ΔapaH strain exhibited the same maximal growth rate as the parental, 
wild-type strain, also upon serial transfer of exponentially growing cultures (Fig 1A and 1B). 
However, when cells grown in LB medium were transferred to minimal medium, the growth 
yield was lower in ΔapaH (Fig 1C). Accordingly, transfer of ΔapaH cells grown to stationary 
phase in minimal medium to fresh minimal medium led to a longer lag phase (Fig 1D). 
Additionally, as previously reported, growth in rich medium at 46 °C was almost completely 
inhibited in ΔapaH and cells exhibited an elongated morphology (Fig 1E and 1F). However, 
cell death was not observed, at least within the first 3 h of incubation at 46 °C (Table 2). As 
described later, we also compared the proteome of the apaH knockout to wild-type, aiming to 
uncover which proteins are up- or down-regulated at elevated Ap4A levels. 
Regulation of ApaH 
Following the apaH knockout characterization, we replaced the endogenous ApaH with 
various Ap4A hydrolase variants, chromosomally encoded and expressed under different 
promoters (Table 1). The S. cerevisiae Ap4A phosphorylase, Apa2, was placed under the 
apaH promoter. Apa2 belongs to the HIT (histidine triad) superfamily. It is not a hydrolase, 
but rather an asymmetrical phosphorylase, generating ATP and ADP from Ap4A and 
phosphate, and shows no homology in structure, or sequence, to E. coli’s ApaH. Both growth 
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inhibition at 46 ºC (Fig 2A) and the longer lag time in minimal medium (Fig 2B) of the apaH 
knockout were complemented by apa2. Accordingly, the cellular level of Ap4A was restored, 
to a level that is ≥10-fold lower than wild-type and below the detection limit of our assay 
(Table 1). Complementation by an enzyme that shares nothing but ApaH’s ability to remove 
Ap4A suggests that the observed apaH phenotype relates directly to elevated Ap4A levels, 
and not any secondary functions of ApaH. Further, if Ap4A has some signaling role in heat-
stress and/or starvation, unregulated removal should have an effect. However, regulation 
(allosteric via a small molecule, or by an E. coli protein regulator) is unlikely to be 
recapitulated by the evolutionarily and biochemically unrelated Apa2. 
Furthermore, upon analyzing ApaH, we found that it exhibits low thermostability (TM  ≈ 50 
°C). This low melting point could relate to signaling of higher environmental temperatures. 
To examine this option, we engineered a thermostable variant of ApaH using computational 
design [36]. We generated an ApaH variant carrying 29 mutations and exhibiting a TM of 64 
°C, well above the observed heat-stress phenotype at 46 °C (mutations are listed in Material 
and Methods section). However, genomic complementation of the endogenous ApaH with 
this variant, ApaH_D7, showed wild-type-like behavior including at 46 °C (Fig 2A and 2B). 
Thus, as indicated by the Apa2 complementation, ApaH regulation at the enzyme level is 
unlikely. 
We also tested complementation by ApaH mutants with impaired activity to detect the 
concentration threshold of Ap4A above which phenotypes are observed (Fig 2A and 2B). 
Active-site mutations may also cause misfolding and loss of protein, as we observed with the 
ApaH mutants. Thus, we used the stabilized ApaH_D7 variant to introduce two active-site 
mutations, H120A and H227A. Both of these mutants produced soluble, folded proteins, yet 
H120A was essentially inactive, while the Ap4A hydrolyzing activity of H227A decreased by 
240-fold compared to wild-type ApaH. Complementation with the enzymatically inactive 
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ApaH-H120A resulted in a phenotype indistinguishable from the knockout strain, apaH. 
The ApaH-H227A mutant resulted in growth inhibition that is slightly weaker than the apaH 
knockout (Fig 2A and 2B) although its Ap4A level was similar to that of ΔapaH (Table 1). 
Since the cellular Ap4A concentrations were compared on the basis of the culture’s optical 
density and dry cell weight, it may well be that the actual Ap4A levels differ due to different 
cellular morphology. 
Replacement of not only of the hydrolase itself (Apa2 instead of ApaH), but also of its 
transcriptional regulation, had no effect either. Specifically, we generated constructs 
expressing Apa2 in the pZA vector – a low copy number plasmid with expression under the 
anhydrotetracycline (AHT) promoter. This construct was expressed in both the ΔapaH and 
the parental strain, alongside a control construct bearing an inactive Apa2 mutant (Apa2-
H161A). Expression of Apa2 or its inactive variant in the parental strain had no effect on 
growth in LB medium at 46 °C (Fig 3A). The growth rate of the Apa2 complemented ΔapaH 
strain in either LB medium at 46 °C, or in minimal medium at 37 °C, was identical to the 
parental K12 strain as long as the inducer, AHT, was present, while ΔapaH cells expressing 
the inactive Apa2 mutant behaved as the ΔapaH strain (Fig 3B and 3C). 
The above results indicated that E. coli growth rate is not affected by replacement its 
endogenous Ap4A hydrolase by another enzyme that removes Ap4A (Apa2). However, small 
differences cannot be detected by parallel growth and monitoring absorbance.  We thus 
performed a direct growth competition between a K12 strain expressing yeast Apa2 (in 
addition to the endogenous ApaH) and an identical control strain expressing an inactive Apa2 
mutant. Expression of active Apa2 resulted in non-regulated removal of Ap4A, and to levels 
below detection (in oppose to ~0.2 µM in the parental K12 strain). To quantify the ratio of 
the competing versus the control cells, the competing strain contained a chloramphenicol 
resistance marker. The effect of chloramphenicol marker was determined by competing K12 
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strains with and without it (both expressing inactive Apa2). The direct competition 
experiment also indicated no significant growth advantage or disadvantage of Ap4A non-
regulated removal neither in LB (Fig 3D) nor in M9-Glc medium (Fig 3E). 
Overall, it appears that ApaH’s function is not regulated, neither at the enzyme level nor 
transcriptionally, and certainly not under the conditions tested here; thus, criteria 1 and 2 are 
not fulfilled. Further, Ap4A levels in the strain expressing yeast Apa2 were significantly 
reduced – ≤ 0.02 µM, compared to 0.2 µM in the wild-type (Table 1), yet within the 
perturbation range expected for a signaling molecule. If Ap4A has a signaling role, altered 
regulation and degradation kinetics should both have some effect (criterion 3 not fulfilled). 
The above results are, however, entirely consistent with Ap4A being a damage metabolite 
that is constitutively removed (criterion 6 met). Its accumulation at low levels has no effect, 
while very high levels (≥ 100-fold compared to wild-type) inhibit growth, but only under 
challenging conditions and without causing cell death (criterion 7 met). 
LysU does not affect the presumed Ap4A-triggered phenotypes 
If degradation of Ap4A is not regulated, perhaps synthesis is. Lysyl-tRNA synthetases 
(LysRS) is considered the main producer of Ap4A in E. coli, with two isoforms, LysS and 
LysU [37]. LysS is constitutively expressed and is likely to be responsible for house-keeping 
aminoacylation. LysU’s expression is thought to be triggered by heat stress, and it has thus 
been suggested to act primarily as an Ap4A synthetase [38,39].  A lysU deletion strain 
(lysU) was reported to grow normally at low temperature (28 °C) but poorly at 44 °C, and 
this growth defect was ascribed to disruption of Ap4A-mediated heat stress signaling [37]. 
Further, E. coli cells evolved to grow at high temperature exhibited elevated lysU levels, and 
its deletion rendered them thermosensitive [40]. However, a later publication reported that 
lysU deletion has no effect on growth at high temperature [41]. Given these conflicting 
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reports, we tested the ΔlysU phenotype. In E. coli K12, we could not identify any significant 
growth difference, or any other observable phenotype, upon deletion of lysU, including at 
elevated growth temperatures. Further, the lysU and the lysS strains showed the very same 
growth rates at ambient and high temperatures in both rich and minimal media.  
Laboratory sub-functionalization of LysRS to generate an Ap4A synthetase 
An enzyme whose primary function is Ap4A synthesis is not known, neither in E. coli nor in 
other organisms. However, in nature, secondary, moonlighting functions often evolve to 
become the primary function of a duplicated, paralogue gene (sub-functionalization) [42]. We 
engineered a sub-funtionalized LysU variant that produced Ap4A yet had no aminoacylation 
function.  
We established an assay for Ap4A synthetase activity in crude cell lysates based on 
luminescent detection of ATP generated upon Ap4A hydrolysis. By combining screens of 
gene libraries and site-directed mutagenesis, we generated a LysU variant capable of 
executing only Ap4A synthesis. The libraries included mutations in and around LysU’s 
active-site aimed at increasing the Ap4A synthetase activity, and consensus mutations to 
compensate for the stability losses associated with the function altering mutations (Table S1). 
Following 3 rounds of mutagenesis and screening for higher synthetase activity, variant A2 
(K178E, L231M, V268T, E362R, E373R, F426Y) was isolated. To abolish the 
aminoacylation activity, we first tried to truncate the N-terminal tRNA binding domain, but 
this resulted in an almost complete loss of activity. We thus mutated 3 residues known to 
mediate tRNA binding (R77A, Q95A, T130A) [43,44]. The new LysU variant, dubbed 
LysU_Ap4Asynth, exhibited ~2-fold increased Ap4A synthetase activity with no detectable 
aminoacylation activity (Fig 4A).  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
LysU_Ap4Asynth was expressed from a pZA plasmid in various E. coli strains, thus enabling 
us to examine the outcome of artificially triggered production of Ap4A. Wild-type LysU, and 
an inactive variant devoid of both aminoacylation and Ap4A synthesis, were used as controls. 
E. coli K12 cells expressing these 3 different LysU variants exhibited the very same growth 
rate as wild-type, including under heat-shock and starvation (Fig 4B) despite the fact that the 
cellular concentrations of Ap4A were up to 4.5-fold higher in the strains over-expressing 
wild-type LysU and its sub-functionalized variant, LysU_Ap4Asynth (Table 1).  
As expected in the ΔapaH strain, over-expression of LysU, and especially of 
LysU_Ap4Asynth, resulted in a longer lag phase in minimal medium (Fig 4C). However, the 
Ap4A concentrations in the ΔapaH cells expressing these LysU variants, or with no LysU 
over-expression, were all similar. This could be due to the fact that Ap4A concentrations 
were measured during the exponential phase and not during the lag phase, and also because 
of biases in the calculated concentrations due to differences in cell morphology.  
The above result is meaningful, because removal of ApaH results in a huge increase in Ap4A 
levels (>300-fold; Table 1) and thus causes a global physiological disturbance. It seems, 
however, that a mild perturbation at the range expected for a signaling molecule has no 
effect. Further, in direct competition assay the ratio between cells expressing 
LysU_Ap4Asynth and cells expressing an inactive LysU variant did not change during 
growth in LB (Fig 4D) or M9-Glc medium (Fig 4E) at 37 °C for 48 h. Thus, a mild increase 
in Ap4A levels does not confer any advantage or disadvantage.  
 
Overall, these data suggest that untimely and elevated Ap4A production has no observable 
physiological effect, unless the accumulating Ap4A is not removed (criterion 7 met). Mild 
increases, e.g. 4-fold, had no observable effect, and particularly not higher resistance to heat-
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stress. If anything, elevated Ap4A levels seem to induce heat sensitivity rather than heat 
resistance.  This result is inconsistent with Ap4A playing a role in specific signaling 
(criterion 3 not met), but is entirely consistent with Ap4A being a damage metabolite.  
Proteomics of E. coli ΔapaH  
We examined the changes in E. coli’s proteome in the apaH knockout whereby Ap4A levels 
are ~350-fold elevated. We opted for growth in minimal medium, and during the exponential 
phase, rather than heat-shock, to examine changes that occur prior to, and not during stress. 
Additionally, although apaH cells did not die at 46 °C, they did not grow and hence limited 
cell mass. Protein intensities in the ΔapaH strain were compared to the parental, wild-type 
strain. We only considered changes in proteins where ≥2 peptides were consistently 
identified. Overall, ~2,000 proteins, namely about half of the E. coli proteome, were reliably 
detected in both conditions.  
The proteome changes were relatively subtle. Only 9 proteins were identified whose levels 
decreased by 2-13-fold in apaH in at least two independent experiments (Table 3). No up-
regulated proteins were observed, not reproducibly and given our analysis criteria.  
 
 
The proteins listed in Table 3 can be divided into 3 groups: (i) proteins regulated by Zur - the 
Zn
2+
 DNA-binding transcriptional repressor (YkgM, ZinT, ZnuA); (ii) enzymes belonging to 
aromatic amino acid biosynthesis pathways (AroF, TyrA, TrpE, TrpA); (iii) proteins that 
regulate the starvation sensing during stationary phase (RspA, RspB). The last two groups are 
related because a shortage of aromatic amino acids is known to be a hallmark of starvation 
[45]. It therefore appears that elevated Ap4A levels result in a lower ability to sense 
starvation, thus accounting for the slower recovery of ΔapaH strain after starvation and 
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probably also for the growth arrest at 46 °C.  Indeed, we observed no indications for a heat-
stress response - most heat-shock proteins and chaperones were reliably detected and showed 
no changes. 
Ap4A and Zn
2+
 homeostasis 
A distinct change in response to elevated Ap4A levels was the decrease in expression of 3 out 
of the 5 operons controlled by the zinc transcriptional factor, Zur. Down-regulation the other 
two operons was also observed (pliG and znuB,C), with a milder, ~1.5-fold decrease. The 
result is in accordance with the affinity of Zur for those operons. The strongest binding was 
reported to the ykgM,O operon and the weakest to pliG [46]. The down-regulation of Zur-
regulated genes, including the Zn2+ importer, suggests that the ΔapaH strain has elevated 
cellular zinc levels, or perhaps that erroneously senses high levels. If the ΔapaH strain has 
increased intracellular zinc concentration, then the apaH knockout strain might exhibit some 
advantage in a Zn2+ depleted media. Indeed, while the parental K12 strain showed no growth 
in minimal medium containing the metal chelator EDTA, the ΔapaH strain grew after a lag 
phase to a final cell density that is similar to that without a chelator (Fig 5). Although EDTA 
chelates a range of bivalent metals including Mg2+ and Ca2+, its affinity towards zinc is ≥ 105-
fold higher, and the concentrations of the latter were higher than that of EDTA. 
Overall, the proteomics data are consistent with the observed phenotype of the ΔapaH strain 
in relation to its compromised response to starvation. Further, these data do not indicate a 
linkage between Ap4A and heat-stress. However, we observed a previously unreported 
linkage between Ap4A and Zn
2+
 homeostasis that may relate to the observation that Ap4A 
binds Zn
2+
 with high affinity [47]. Although the affinity measurement was later questioned 
[48], Zn
2+
 is also known to activate the Ap4A synthetase activity of AARS [49]. However, 
while Ap4A may contribute to zinc storage under some conditions, a specific role for Ap4A 
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in sensing Zn
2+
 depletion is unlikely, given that, as discussed in the next section, none of the 
identified putative Ap4A binders are associated (regulatory, or otherwise) with Zn
2+
 
homeostasis.  
Identification of Ap4A binding proteins in E. coli 
If Ap4A is part of a signaling network, this network must involve selective Ap4A binding to 
at least one protein. Previous attempts to identify Ap4A binders yielded few putative targets 
including DnaK [20], ClpB [50], GroEL [20] and IMPDH [51]. We attempted to identify 
Ap4A binding proteins by pull-down with biotin labeled Ap4A. We tested several 
biotinylated analogs, yet the only one that gave consistent results had the biotin tethered to 
the N8 of the adenine ring (as opposed to attachment via the ribose or adenine-N6). Owing to 
the minimal interference of N8 modification, this analog was also the only one that could be 
enzymatically synthesized from N8-biotinylated ATP using Apa2, the yeast Ap4A 
phosphorylase, which catalyzes the conversion of adenosine-5’-phosphosulfate (APS) and 
ATP into Ap4A [52]. Pull-downs were performed in two alternative modes: The lysate was 
pre-incubated with biotin-Ap4A, and the streptavidin beads were added later; or, with 
streptavidin beads pre-coated with biotin-Ap4A. In both modes, ATP was present in the 
binding step to favor selective Ap4A binders. After extensive washing, the remaining, bound 
proteins were identified by shotgun proteomics. As controls, pull downs were performed with 
either biotin, or biotin-ATP.  
Potential Ap4A binders were identified on the basis of a cumulative score that included 3 
criteria: (i) The number of unique peptide fragments that are observed (2 as a minimum); (ii) 
> 2-fold enrichment in the biotin-Ap4A samples relative to the biotin and biotin-ATP 
controls; (iii) consistent enrichment in more than one pull-down. The highest scoring proteins 
are listed in Table 4. A few of these were previously implicated with Ap4A binding (IMPDH, 
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DnaK). Interestingly, most of these putative Ap4A binders are regulatory proteins, with 
particular enrichment of ssDNA binding proteins. However, although all pull-downs were 
done in the presence of ATP to minimize unspecific binding, nearly all the identified proteins 
are known ATP binders. 
The two proteins showing the highest enrichments in all pull-down experiments were inosine 
monophosphate dehydrogenase (IMPDH; previously implicated with Ap4A [51]) and a 
transcriptional regulatory protein, NrdR. These were further characterized to determine if 
Ap4A binding is biologically relevant.  
IMPDH binds Ap4A but with no selectivity over ATP 
IMPDH catalyzes the NAD-dependent oxidation of inosine-5'-monophosphate (IMP) to 
xanthosine 5’-phosphate (XMP) [53]. Bacterial IMPDHs possess an additional domain, a 
cysthathionine β-synthase (CBS) domain, that acts as transcriptional regulator [54] in 
maintaining the ATP/GTP pool [55]. Accordingly, the CBS domain binds phosphorylated 
nucleosides such as ATP or AMP that may comprise allosteric regulators of IMPDH, and 
also binds ssDNA [56]. Bacterial IMPDHs are divided to two classes: Class I comprises 
enzymes that are allosterically activated by ATP and are permanently octameric; Class II 
enzymes exhibit ordinary kinetics, are tetramers in the apo state, and shift to octamers in the 
presence of NAD or ATP [57]. E. coli’s IMPDH (ecIMPDH) belongs to Class II, yet aiming 
to examine how evolutionary conserved Ap4A binding is, we also tested a IMPDH from P. 
aeruginosa that belongs to Class I.  
In agreement with its dominance in pull-downs, purified ecIMPDH exhibited tight binding to 
biotinylated-Ap4A (Fig 6A). Soluble ATP or Ap4A did not inhibit binding, suggesting a 
large avidity effect (multiple immobilized Ap4A molecules and IMPDH’s octameric state). 
Using radioactively labeled Ap4A and equilibrium dialysis, we confirmed that ecIMPDH 
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binds soluble Ap4A with 5-fold higher affinity than ATP. This affinity ratio indicates that 
Ap4A binding is physiologically irrelevant. Cellular ATP concentrations in E. coli are in the 
range of 1-10 mM [58,59] while Ap4A’s concentration is in the range of 0.2 µM (Table 1). In 
fact, ATP dominates (≥ 14-fold molar excess) even at the abnormally high Ap4A 
concentrations observed in the apaH knockout (~70 µM).  
Indeed, we could not identify any physiologically relevant modulation of ecIMPDH by 
Ap4A. Neither ATP nor Ap4A influenced the enzymatic activity of ecIMPDH (Fig 6B). Both 
ligands inhibited the binding of ecIMPDH to ssDNA, but in the same manner, and in any 
case, significant inhibition by Ap4A was only observed at 0.1 mM, i.e., at a physiologically 
irrelevant range (Fig 6C). 
In contrast to the Class II ecIMPDH, the Class I IMPDH of P. aeruginosa (paIMPDH) is 
allosterically activated by ATP [60]. We found that Ap4A is a weaker allosterically activator 
of paIMPDH and competes for the same binding site as ATP (Fig 6D). However, the effect of 
Ap4A could only be observed at ATP concentrations below 1 mM (Fig 6E and Fig 6F). 
Further, even at 0.1 mM ATP (10-fold below the minimal reported cellular concentration), 
the effect of Ap4A was only seen at 10 µM (50-fold above the normal cellular levels).  
Overall, our results indicate that although in vitro Ap4A binds and modulates IMPDHs 
belonging to both Class I and II, in vivo Ap4A is unlikely to be relevant because its effects 
are completely masked by ATP. From the point of view IMPDH’s physiological role, our 
results suggest that ATP comprises an inhibitor of ssDNA binding. Thus, ATP is not only an 
allosteric and oligomeric regulator of IMPDHs [60], but may also affect their function as 
transcriptional regulators. Specifically, IMPDHs have been suggested to suppress 
transcription of genes involved in adenylate nucleotide synthesis [56] and our results suggest 
that ATP binding to the CBS domain of IMPDH may alleviate this suppression. 
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NrdR also binds Ap4A as an ATP surrogate 
The second-best Ap4A binder identified by our pull-downs was NrdR – a zinc-finger 
transcriptional regulator that modulates the expression of several operons encoding 
ribonucleotide reductases (RNRs) according to the abundance of deoxyribonucleoside 
triphosphates (dNTPs) relative to ribonucleotides (NTPs) [61,62]. NrdR has been reported to 
bind ATP [62]. We confirmed NrdR’s strong affinity to biotinylated Ap4A immobilized onto 
streptavidin plates, as opposed to no binding of immobilized ATP (Fig 7A). Subsequently, we 
compared the effect of Ap4A and ATP on NrdR’s binding to DNA. NrdR regulates RNRs 
expression through binding to so-called ‘NrdR boxes’, 16 bp motifs within RNRs promoters. 
We used a 237 bp dsDNA stretch that corresponds to nrdA promoter region and assayed 
NrdR’s binding as for IMPDH. Although Ap4A showed a slightly stronger inhibitory effect, 
under our assay conditions, ATP completely inhibited DNA binding at 0.1 mM 
concentrations (Fig 7B).  
Other putative Ap4A binding proteins 
The effect of Ap4A on DNA binding was also tested for transcriptional regulators HU and 
HNS, which were also identified in the pull-downs, but our in vitro assays indicated that 
Ap4A did not modulate DNA binding of these proteins.  
DnaK and ClpB are reported Ap4A binders [20,50] and DnaK was also identified in our pull-
downs. Both proteins (DnaK, ClpB) are part of a chaperone complex that includes DnaJ and 
GrpE [63]. We tested the effect of Ap4A on the refolding activity of the DnaK-DnaJ-GrpE-
ClpB complex but did not observe a significant effect. Since the DnaK-DnaJ-GrpE complex 
is also involved in bacteriophage λ DNA replication, we tested the effect of ATP and Ap4A 
on ssDNA binding. ATP strongly activated DnaK’s binding to ssDNA while Ap4A had no 
effect.  
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In conclusion, the pull-down experiments did not identify selective Ap4A binders, let alone 
proteins where Ap4A binding has potential relevance in vivo. As is clear from the detailed 
analysis of IMPDH and NrdR, Ap4A binds these proteins as an ATP surrogate. Furthermore, 
although IMPDH and NrdR bind Ap4A at the µM range, and in some in vitro assays exhibit 
higher affinity to Ap4A compared to ATP, a biological relevance is unlikely. Firstly, because 
the cellular ATP concentrations are normally ≥ 5,000-fold higher compared to Ap4A (1-10 
mM versus 0.2 µM, respectively). Secondly, none of the genes/proteins that are under 
regulation of the proteins identified as potential Ap4A binders exhibited changes in 
expression in the apaH knockout. For example, the levels of proteins under NrdR’s 
regulation (NrdA, NrdB, NrdE, NrdI) did not change at elevated Ap4A levels (Table 3). 
Thus, the effects of Ap4A on NrdR do not seem to differ from those of ATP, certainly not in 
the concentration range that is physiologically relevant. Conversely, none of the proteins 
whose expression significantly changes in apaH knockout is linked, even indirectly, to the 
identified Ap4A binders (criterion 4 not met). 
 
Discussion 
It is generally easier to prove the existence of a given biological mechanism, or entity, than to 
prove its absence (which in some cases, would be impossible). Nonetheless, a set of Occam’s 
razor criteria can be applied to distinguish between two alternative hypotheses: a damage 
metabolite versus a specific signaling role. In the case of Ap4A in E. coli, all criteria for 
damage metabolite were met as opposed to none of those indicating specific signaling. 
However, it is clear that these results do completely not rule an involvement of Ap4A in 
signaling. Firstly, our assays were limited to starvation and heat stress, and Ap4A could be 
involved in signaling other challenges. Secondly, Ap4A could be indirectly involved, for 
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example, via the modulation of other alarmones such as ppGpp. Finally, a lack of signaling 
function in E. coli does not exclude the possibility that Ap4A acts as secondary messenger, 
and especially in mammalian cells [64]. The new tools we have established allow controlled 
perturbations of cellular Ap4A concentrations. Beyond the routinely applied knockout of 
Ap4A hydrolase, an Ap4A synthetase is now available that may assist the identification of 
signaling roles of Ap4A, in E. coli or another organism. 
Given the complexity of the cellular milieu, we recognize the risk of claiming that we have 
exhausted the search for function. On the other hand, not every compound in the cell must 
have function. There exists a Panglossian tendency to assume that “any trait has to have a 
good use to explain its presence”. However, “the default assumption should now be that the 
products of metabolite damage are merely adventitious, particularly if there is an efficient 
system to remove them” [31]. As shown here, Ap4A is not only efficiently removed in E. 
coli, but also constitutively – neither the expression nor the enzymatic activity of its Ap4A 
hydrolase are regulated. Additionally, only massive accumulation of Ap4A such in the case 
of ApaH knockout induces phenotypic changes. Unlike in the case of alarmone where even 2-
fold increase above basal level has effect, slight Ap4A increase or decrease observed with 
expression of LysU variants, and Apa2, respectively, did not affect cell fitness. Effects of 
mild Ap4A increase or decrease were not observed even in growth competitions that can 
detect relatively subtle effects. These results are in clear contrast to what had been observed 
with other alarmones, most distinctly with ppGpp that bears obvious analogy to Ap4A. Subtle 
changes in ppGpp levels, in the order of 10-fold, affected growth rate [23]. Over-expression 
of ppGpp synthase results in severe growth inhibition [27], while strains lacking ppGpp show 
complex phenotypes, from amino acid auxotrophy to morphological changes [26]. 
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Our results also indicate two potential toxic effects of Ap4A accumulation. Firstly, Ap4A 
mimics ATP. The pull-down experiments identified known ATP binders. Their 
characterization indicated that Ap4A can displace ATP and inhibit those proteins. Indeed, 
enzyme inhibition by mimicry is a common effect of damage metabolites. For example, 
spontaneously modified products of NADH and NADPH at neutral pH, cannot serve as 
electron acceptors or donors, but they bind and inhibit dehydrogenases [65]. Secondly, high 
Ap4A concentrations seem to disrupt Zn
2+ 
homeostasis. The proteome analysis revealed that 
high Ap4A levels inhibit expression of Zn
2+ 
importers. Accordingly, the growth advantage of 
the apaH strain in Zn2+-deficient medium suggests that high Ap4A levels lead to increase in 
Zn
2+ 
levels.   
In E. coli, and as far as we know, in other organisms, Ap4A is not produced by a dedicated 
enzyme, but rather, it is a side-product of one of the most ancient and essential enzyme 
classes, AARSs. Although Ap4A is probably present in all organisms, not all aminoacyl-
tRNA synthetases produce it, certainly not to the same degree. This observation, and the 
deleterious effects of accumulating Ap4A, may suggest that, unless beneficial, Ap4A 
production by AARSs would have been eliminated by evolution. However, whether Ap4A 
production can be eliminated with no effect on AARS function is unknown. Thus, AARSs 
could be yet another example, out of many, where the most accessible evolutionary solution 
was an enzyme that degrades the damage metabolite rather than eliminating its production in 
the first place. 
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Material and methods 
Bacterial strains and procedures 
The applied E. coli strains are listed in Table 1. E. coli K12 ΔapaH strain was generated by 
P1 transduction [66] using the apaH knockout from Keio collection [67] as a starting point. 
The strains where the apaH gene was replaced with other genes were generated using the λ-
red system [68], whereby the kanamycin cassette in E. coli K12 ΔapaH strain was replaced 
with the open reading frame of the complementing gene followed by a chloramphenicol 
cassette. 
The open-reading frame (ORF) of the apa2 gene (Gene ID: 852143) was PCR amplified from 
the genome of S. cerevisiae ATCC 204508/S288c, and cloned into a pZA vector with 
anhydrous tetracycline inducible promoter [69]. The list of primers used for cloning is 
provided as Table S2. The inactive variant Apa2-H161A was generated by site directed 
mutagenesis [70]. Plasmids were transformed to E. coli K12 or its ΔapaH strain, using 
ampicillin (100 µg/ml) as a selection marker.  
Growth experiments were done in LB, or in M9 medium plus 0.4 % glucose (M9-Glc) 
without presence of antibiotics. A pre-culture in LB, or M9, with antibiotics (2 ml; grown for 
24 h), was diluted to OD600nm = 0.2, and 3 µl inoculates were transfer to 150 µl of LB, or 
M9-Glc, in 96-well microtiter plates. Growth was subsequently followed in a plate reader 
(BIO-TEK, Synergy HT), at 37 °C with shaking (for 30 s with 5 min intervals) while 
monitoring OD600nm. Growth at elevated temperature was followed in LB. Inoculating an LB 
culture as above, and growing in a plate reader at 46 °C. The inoculated culture was overlaid 
with 100 µl of mineral oil to prevent evaporation. Growth of strain carrying pZA plasmids 
(encoding ApaH, Apa2 or LysU variants) was done as above, except that ampicillin, and 
anhydrous tetracycline (AHT; 200 ng/ml) as inducer, were added. 
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Growth competitions  
We used two platform strains, both containing E. coli’s original ApaH gene: unmodified E. 
coli K12, or E. coli K12 ΔapaH::apaH-CAP that  contains the original apaH gene alongside a 
chloramphenicol (CAP) cassette used as a marker. E. coli K12 that carried pZA_Apa2 
H161A plasmid (inactive Apa2) served as the reference strain. The competing strains were 
based on E. coli K12 ΔapaH::apaH-CAP. They carried either pZA_Apa2 H161A plasmid 
(inactive apa2) or  pZA_Apa2 (active apa2). These strains were grown separately in LB plus 
Amp (100 µg/ml) until OD600nm ~ 1. They were then mixed at a 1:1 ratio. An aliquot of this 
mix was immediately diluted and plated in parallel on LB agar plus Amp, and LB agar plus 
Amp plus CAP, to measure the initial cell counts of each strain. Another aliquot of the 
starting mix was diluted 1000-fold in 8 ml of LB plus Amp plus AHT (100 ng/ml), and in 8 
ml of M9-Glc plus Amp plus AHT (100 ng/ml). After 24 h growth at 37 °C (200 rpm, 50 ml 
falcon tubes), the resulting cultures were plated in parallel on selective LB agar to measure 
the cell counts of the two competing strains. An aliquot of 24 h culture was diluted 1000-fold 
in the fresh medium (serial passage) and after 24 h of growth at 37 °C the cultures were 
plated again on selective agar to measure the cell counts. 
The control competition was of [E. coli K12 pZA_Apa2 H161A] versus [E. coli K12 
ΔapaH::apaH-CAP pZA_Apa2 H161A] thus determining the effect of chloramphenicol 
cassette at wild-type like Ap4A levels (inactive Apa2, in both strains). Subsequently, [E. coli 
K12 pZA_Apa2 H161A] was competed versus [E. coli K12 ΔapaH::apaH-CAP pZA_Apa2] 
to measure the fitness effects associated with decreased Ap4A level.  
The same procedure was used for the fitness assay with the increased levels of Ap4A. E. coli 
K12 carrying pZA_InT plasmid (inactive variant of LysU) was competing against E. coli K12 
ΔapaH::apaH-CAP pZA_InT and E. coli K12 ΔapaH::apaH-CAP pZA_Ap4Asynth. 
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Data are presented as percentage of selected strain (number of colonies on LB agar + Amp + 
CAP) versus total cell number (number of colonies on LB agar + Amp) with standard 
deviation from 3 biological replicas. 
ApaH cloning, purification, activity and thermal denaturation assay 
The ORF of apaH gene (Gene ID: 944770) was PCR amplified from the genome of E. coli 
K12 and cloned into a pET-21a vector with a C-terminal 6-His tag. A synthetic gene 
encoding the designed ApaH_D7 (D7 design contains following mutations: I17Q, H21D, 
E24N, T26D, G28K, D47K, Y51F, F74A, S78R, K114R, T124A, Q130E, D138E, S147N, 
F150W, D153E, H162R, R168T, G171D, N189D, Q191R, Y195K, S196C, P206E, G215S, 
A218S, E219K, S222N, E238P) was cloned in pET21a vector with the same tag. The H120A 
and H227A mutants of ApaH_D7 were generated by site directed mutagenesis. The 
recombinant plasmids were transformed into E. coli BL21 (DE3) and cultured in 100 ml LB 
medium. Protein expression was induced with 1 mM IPTG at OD600nm ≈ 0.6. After being 
cultured for another 6 h at 37 °C, cells were harvested, collected by centrifugation, and 
resuspended in 5 mL of lysis buffer (50 mM HEPES, pH 7.8, and 150 mM KCl, 15 mM 
imidazole). After sonication and removal of pellet, the proteins in the supernatant were 
loaded on a Ni-NTA column that was pre-equilibrated with the binding buffer (50 mM 
HEPES, pH 7.8, and 150 mM KCl). The ApaH variants were eluted with 200 mM imidazole, 
elution fractions were pulled, the buffer was exchanged to 50 mM HEPES, pH 7.8, 150 mM 
KCl, 7 mM MgCl2, and the proteins concentrated to 0.15 mg/ml, 9 mg/ml, 7.8 mg/ml, 4.1 
mg/ml wild type ApaH, ApaH_D7, ApaH_D7 H120A and ApaH_D7 H227A, respectively. 
Protein purity was assessed by electrophoresis and the samples were stored at -20 °C.  
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The thermal stability of ApaH variants was measured following heat-induced unfolding. 
Solutions of 15 μM enzyme containing 5× SYPRO Orange dye (Invitrogen) were heated 
from 4 to 99 °C in a 7500 Fast Real-Time PCR system (Applied Biosystems) and unfolding 
was followed by measuring the change in fluorescence excitation, 488 nm; emission, 570 
nm). Measurements were conducted in duplicates and the midpoint of denaturation (TM) was 
determined as the maximum of the first derivative for each temperature. 
Ap4A hydrolase activity was assayed using 0.15 μM (wild type, and stabilized variant) or 12 
μM (D7 variants H120A and H227A) enzyme, 1 mM Ap4A, in 50 mM HEPES, pH 7.8, and 
150 mM KCl, 7 mM MgCl2. Aliquots of the reaction mixtures (1.5 µl) were taken at after 5, 
10 and 60 min, and analyzed by thin-layer chromatography (TLC) using silica-gel-60 plates 
with fluorescent indicator (Merck; catalog no. 5554). The mobile phase comprised a mixture 
of isopropanol:2,4-dioxane:water:25 % ammonia solution at a ratio of 2:4:4:3 [71]. The plates 
were dried and visualized by UV light. Samples were run in duplicates and the UV images 
were analyzed by IMAGEJ. 
Cloning, expression and purification of Apa2  
Full-length apa2 gene (Gene ID: 852143) was PCR amplified from the genome of S. 
cerevisiae ATCC 204508/S288c and cloned into a pET- 21a vector, with an C-terminal 
hexahistidine tag. The recombinant plasmid was transformed into E. coli BL21 (DE3) 
cultured in 100 ml LB medium. The expression of the proteins was induced with 1 mM IPTG 
when OD600nm reached 0.6. After being cultured for another 16 h at 20 °C, cells were 
harvested and collected by centrifugation at 4000 g for 15 min, and resuspended in 5 mL of 
lysis buffer (20 mM TRIS, pH 7.8, and 150 mM KCl, 15 mM imidazole). The purification 
procedure is the same as described above for ApaH. Purified protein (5.7 mg/ml) in 20 mM 
TRIS, pH 7.8, and 150 mM KCl buffer was stored at -20 °C for further use.  
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LysU engineering and characterization 
The ORF of lysU gene (Gene ID: 948645) was PCR amplified from the genome of E. coli 
and cloned into pET-21a, with an C-terminal 6-His tag. The lysU gene library was generated 
using the ISOR method [72], including functional mutations in aminoacylation domain and 
consensus mutations derived from a sequence alignment (the list of library mutation primers 
is in Table S2). The assembly PCR was optimized to yield ~2.5 mutations per gene, thus 
resulting in ~ 50 % of active clones.  
The library was cloned in pET-21a and transformed into E. coli BL21 (DE3) cells. Single 
colonies were inoculated in 500 µl LB media and grown overnight at 37 °C in deep-well 
plates. This preculture (8 µl) was used to inoculate 800 µl of 2YT medium. After 2.5 h of 
growth at 37 °C with shaking, expression was induced with 1 mM IPTG, and growth was 
continued for 6 h at 37 °C. The cell pellet was lysed in 20 mM TRIS pH 7.5, 150 mM KCl, 7 
mM MgCl2 with bensonase (1 U/µl), lysozyme (0.3 mg/ml) and protease inhibitor (Sigma 
Aldrich, S8830). For assaying Ap4A synthesis, 5 µl of clarified lysate was added to 45 µl of 
reaction buffer (20 mM TRIS pH 7.5, 150 mM KCl, 7 mM MgCl2) plus mixture with 1 mM 
ATP. The reaction was incubated for 1 h at 37 °C and stopped by heating (5 min at 65 °C). 
The unreacted ATP was hydrolyzed by calf intestine phosphatase (4 U) for 3 h min at 37 °C, 
and the phosphatase was inactivated by heating at 85 °C for 5 min. A 10 µl aliquot of the 
inactivated reaction mix was added to 9.75 µl aliquot of the luciferase ATP determination kit 
(LBR-T010, Proteinkinase.de) plus recombinant human Ap4A hydrolase in order to 
hydrolyze the synthesized Ap4A to AMP and ATP (0.25 µl of 1 mg/ml; the enzyme was 
cloned in pET-21a with C-terminal His tag and purified as Apa2). The assay was calibrated 
such that the amount of ATP generated by Ap4A hydrolysis was proportional to the 
luminescence signal. The first-round variants that showed higher activity that wild-type LysU 
were reshuffled to generate the second library. The variants with the highest Ap4A synthetase 
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activity were characterized as described below. The mutations in the tRNA binding domain 
(R77A, Q95A, T130A) were introduced by site directed mutagenesis protocol [70].  
The engineered LysU variants were expressed in E. coli BL21 (DE3) cells cultured in 100 ml 
LB. Expression was induced with IPTG, and growth was continued for 6 hr as above. The 
purification procedure was the same as for Apa2 described above. 
Ap4A synthesis and aminoacylation assay 
Ap4A synthesis was assayed by the luminescence assay or by HPLC. The reaction mixture 
contains 0.05 mg/ml LysU variants, 2.5 mM ATP and 0.2 mM lysine, in 20 mM TRIS pH 
7.5, 150 mM KCl, 7 mM MgCl2. At different time points, aliquots of 10 µl were added to 
acetonitrile (10 µl), diluted 5 times in water, filtered through 0.2-µm filters (0.22 µm, Millex-
GV 4 mm PVDF, Merck-Millipore) and loaded on ion-exchange HPLC column (SAX-NP5, 
50x4.6 mm). The mobile phase comprised 10 mM TRIS pH 7.2, and elution with a gradient 
of NaCl (from 0 to 0.5 M NaCl in 10 minutes). The faction of ATP and Ap4A was 
determined by relative peak intensities (OD260nm).  
Aminoacylation was assayed in 50 µl reactions, contacting 0.1 mg/ml LysU variants, 2 mM 
ATP, 0.2 mM lysine (spiked with 1 µCi of 
3
H labeled lysine, Perkin Elmer NET376250UC) 
and 10 µM tRNALys, in 20 mM TRIS pH 7.5, 150 mM KCl, 7 mM MgCl2, incubated at 37 
°C for 2-12 h. Reactions were stopped by addition of 100 µl of salmon sperm DNA (1 mg/ml, 
in sodium acetate pH 3.0) followed by 150 µl of 20 % TCA. The pellet was isolated and 
washed 4 times with 5 % TCA containing 0.2 mM cold lysine by centrifugation. The last 
washing was with 96 % ethanol, and the precipitate was then dried and dissolved in 75 µl of 
0.1 M NaOH. The resuspended samples were added to 3 ml of liquid scintillation cocktail 
(Ultima Gold; Perkin Elmer) and analyzed in a liquid scintillation analyzer (Packard TRE-
CARB 2100TR). 
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Determination of cellular Ap4A concentrations 
Extract preparation 
E. coli K12 wild type and ΔapaH cultures were grown in M9-Glc for 24 h , and used to 
inoculate a fresh 10 ml culture of M9-Glc (at 100 dilution).  The cultures were grown with 
shaking at 37 °C and cells were pelleted by 3 min centrifugation at 10000 g, at OD600nm ≈ 0.3 
(exponential). The cell pellets were frozen in liquid nitrogen and analyzed by MS. The 
samples were extracted with methanol-acetonitrile-water [40:40:20] with 0.1 N formic acid. 
The internal standard mix (15 µL) was added to the extracts, and the obtained mixtures were 
concentrated in speedvac to eliminate extraction solution, and then lyophilized till dryness. 
Before LC-MS analysis the obtained residues were re-dissolved in 50 µl of starting eluent (70 
% A/30 % B), and filtered through 0.2-µm filters (0.22 µm, Millex-GV 4 mm PVDF, Merck-
Millipore) to remove insoluble material.  
Preparation of internal standard mix 
13
C10-ATP (2 mM, Sigma Aldrich cat. number 710695) was reacted with 0.25 mM lysine and 
LysU enzyme (0.1 mg/ml) to produce 
13
C20-Ap4A. The reaction progress was followed by 
TLC (method described above), at 10 % of conversion the enzyme was eliminated by 
addition of acetonitrile (1:1 v/v) to prevent further reaction progress. Precipitated enzyme 
was removed by centrifugation, solution diluted 2-fold in water and filtered through 0.2-µm 
filters. To prepare internal standard mix stock, the reaction mixture was diluted in water 
providing 5 µM concentration of 
13
C20-Ap4A and 45 µM of 
13
C10-ATP. 
LCMS analysis 
The LC-MS/MS instrument consisted of Acquity I-class UPLC system (Waters) and Xevo 
TQ-S triple quadrupole mass spectrometer (Waters) equipped with an electrospray ion source 
and operated in positive ion mode was used for analysis of nucleoside phosphates. MassLynx 
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and TargetLynx software (v.4.1, Waters) were applied for the acquisition and analysis of 
data. The analysis was done on a 50 x 2-mm i.d., 3-µm 100 Å Luna-NH2 column equipped 
with 4.0 x 2.0 security guard amine cartridge (both Phenomenex) with mobile phases A (10 
mM ammonium formate, pH 5.0 adjusted with 10 % acetic acid, followed by addition of 40 
mL of acetonitrile) and B (1 mM ammonium formate, pH 10.6 adjusted with 29 % ammonia, 
followed by addition of 17 mL of acetonitrile) at a flow rate of 0.3 ml/min and column 
temperature 25°C. A 10-minute gradient was as follows: linear increase from 30 to 70 % B 
during 4 minutes, then increase to 90 % in 0.5 minute, followed by return to 30 % B in the 
next 0.5 minute, and equilibration for 5 minutes. Samples kept at 4°C were automatically 
injected in a volume of 5 μl. 
For mass spectrometry argon was used as the collision gas with flow 0.10 ml/min. The 
capillary voltage was set to 2.50 kV, source temperature - 150°C, desolvation temperature - 
600°C, desolvation gas flow - 800 L/h. Analytes were detected using multiple reaction 
monitoring (MRM) applying following parameters: Ap4A (retention time 3,57 min; transition 
837.1>136.2 (cone 14 V, CE 35 eV); transition 837.1>348.2 (cone 14 V, CE 26 eV)), 
13
C20-
Ap4A (retention time 3,57 min; transition 857.1>141.1 (cone 14 V, CE 35 eV); transition 
857.1>358.1 (cone 14 V, CE 26 eV)), 
13
C10-ATP  (retention time 3,90 min; transition 
518.0>141.1 (cone 14 V, CE 35 eV); transition 508.0>358.1 (cone 14 V, CE 18 eV)). 
Cellular concentration was determined in two ways: based on the dry weight of the extracted 
cells and OD600nm. The total intracellular volume: the dry weight of the extracted cells 
(measured using cultures that are treated identically to those used for metabolite extraction) 
multiplied by the ratio of aqueous volume to cellular dry weight. The ratio of aqueous volume 
to cellular dry weight is 0.0023 liter g/1 for E. coli [73]. The total intracellular volume 
calculated on the basis of the OD600nm: total number of cells (OD600nm = 1 corresponds to 10
9
 
cells/ml) multiplied by the single cell volume (1 µm
3
 [74]). The measured concentration was 
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multiplied with dilution factor (sample volume/total cellular volume) to determine 
intracellular concentration of Ap4A. Concentrations calculated by both methods were similar. 
Synthesis of biotin labeled Ap4A 
Synthesis of 8-[(6-amino)-hexyl]-amino-Ap4A-biotin 
The reaction mixture contained 0.25 mM 8-[(6-amino)-hexyl]-amino-ATP-biotin (NU-807-
BIO, Jena Bioscience), 0.5 mM adenosine-phosphosulfate (APS) and 0.25 mg/ml Apa2, in a 
reaction buffer of 50 mM HEPES, pH 7.8,150 mM NaCl and 1 mM MgCl2. The reaction was 
analyzed by HPLC (ion-exchange, as above). Apa2 was removed from reaction mixture by 
centrifugation through 10 kDa cut-off spin column (Millipore) and samples were stored at -20 
°C. Using the same protocol, 
3
H-labeled Ap4A was synthesized from 
3
H-ATP 
(NET420250UC, Perkin Elmer). 
Synthesis of PEG3-biotin Ap4A 
In a round bottom vial, 0.012 mmol (10.0 mg) of Ap4A (Sigma) and 0.014 mmol (2.33 mg) 
of carboxydiimidazole (CDI) were added in 70 l of water. The vial was vibrated for 30 
minutes, after which PEG3-Biotin (Pirece) was added. The vial was vibrated overnight at 
room temperature and product formation was monitored by TLC (dioxane/isopropyl alcohol/ 
25% NH4OH/ 6 mM EDTA; 4:2:3:4). Water was removed by lyophilisation and the crude 
product was obtain as waxy white solid.
 1
H-NMR and 
31
P-NMR were recorded in D2O at 
ambient temperature (20°C) operating at 300 MHz and 121.5 Mhz respectively.  
 
1
H-NMR (300 MHz, D2O)  8.34 (2H, s), 8.06 (2H, s), 5.96 (2H, d), 4.68 (2H, t), 4,51(3H, 
m), 4,23-4,00 (7H, m), 3.60-3.40(12H,m), 3.20 (2H, m), 3.10 (1H,m), 3.01 (2H, t), 2.80 (1H, 
m), 2.58 (1H, m),  2,11(2H, m), 1.59-1.1 (6H, m). To be noted is the upfield shift of the 
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triplet due to the methylene group (3.01 ppm, -CH2-CH2-NH-P(O)(OR2)-) in alpha position 
respect to the terminal amine of the PEG3-Biotin chain (2.68 ppm, -CH2-CH2-NH2). 
31
P-
NMR (121.5 MHz, D2O)  -10.30, -22.13. 
It appears, however, that the p-NH- bond was unstable, thus making this mode of coupling 
inapplicable for pull-downs. 
Proteomics and pull-down experiments  
Proteomics: The culture was prepared in the same way as described above for metabolomic 
analysis. The cell pellets were frozen in liquid nitrogen and analyzed by MS.  
Pull-down experiments: E. coli K12 MG1655 cells were cultured in 10 ml of LB medium and 
pelleted at OD600 ≈ 0.5. Cell pellets were isolated by centrifugation, washed and resuspended 
in 50 mM HEPES, pH 7.8,150 mM NaCl and 1 mM MgCl2. Cells were disrupted by 
sonication. The total protein concentration was measured by BCA kit (23227, 
ThermoScientific) and all lysates were all diluted to 2 mg protein/ml. Pull-downs were 
performed with either pre-coated magnetic beads (Merck Millipore, LSKMAGT10), or by 
pre-incubation with biotinylated ligands. Overall, 3 parallel pull-down experiments were 
performed.  Experiment #1 included the following steps: (1) The rinsed beads (1 mg) were 
incubated with 100 µl of 20 µM biotin, bioATP, or bioAp4A, for 1 h at 4 °C; (2) Unbound 
ligands were removed by rinsing with HEPES buffer (7x250 µl); (3) 50 µl of E. coli lysate 
and 50 µM ATP were incubated with biotinylated beads for 1.5 h at 4 °C; (4) Unbound 
proteins were removed by rinsing with HEPES buffer (7x250 µl) and beads were analyzed by 
MS. Experiment #2 included the following steps: (1) 25 µM biotin, bioATP or bioAp4A, 
were incubated with E. coli lysate plus 50  µM  ATP (100 µl total volume) for 1 h at 4 °C; (2) 
Rinsed beads (1 mg) were added to the above mixture and incubated for an hour at 4 °C; (3) 
Unbound proteins were rinsed by washing with HEPES buffer (7x250 µl) and beads were 
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analyzed by MS. Experiment #3 included the following steps: (1) Beads (4 mg) were 
incubated with 400 µl of 25 µM bioAp4A for 1 h at 4 °C; (2) Unbound ligand was removed 
by rinsing with HEPES buffer (7x250 µl); (3) BioAp4A beads were incubated with 200 µl of 
E. coli lysate plus 50 µM ATP for 1.5 h at 4 °C; (4) Unbound proteins were removed by 
rinsing with HEPES buffer (7x250 µl), and in the last rinse, the beads were split into 4 
aliquots (4x100 µl) and buffer was removed; (5) Proteins bound to BioAp4A beads were 
eluted with 100 µl of HEPES buffer, 10 µM, 50 µM, or 100 µM Ap4A solution, and analyzed 
by MS. 
 
For the MS analysis, samples were subjected to in-solution, on-bead, tryptic digestion. 
Proteins were first reduced by incubation with dithiothreitol for 30 min at 60°C, and alkylated 
with 10 mM iodoacetamide in the dark for 30 min at 21 °C. Proteins were then subjected to 
digestion with trypsin (Promega; Madison, WI, USA) for 16 h at 37°C. The digestions were 
stopped by trifluroacetic acid (1%). Following digestion, peptides were desalted using solid-
phase extraction columns (Oasis HLB, Waters, Milford, MA, USA). The samples were stored 
in -80˚C until further analysis. For lysate analysis, samples were subjected to in-solution 
tryptic digestion using a modified Filter Aided Sample Preparation protocol (FASP). Sodium 
dodecyl sulfate buffer (SDT) included: 4 % (w/v) SDS, 100 mM TRIS pH 7.6, 0.1 M DTT. 
Urea buffer (UB): 8 M urea (Sigma, U5128) in 0.1 M TRIS pH 8.0 and 50 mM Ammonium 
Bicarbonate. Cells were dissolved in 100 μL SDT buffer and lysed for 3 min at 95 °C. Then 
spin down at 16,000 RCF for 10 min. 100 µg were mixed with 200 μL UB and loaded onto 
30 kDa molecular weight cutoff filters and spin down. 200 μl of UB were added to the filter 
unit and centrifuge at 14,000 x g for 40 min. Alkylation using 100 µl IAA, 2 washed with 
Ammonium Bicarbonate. Trypsin was then added and samples incubated at 37 °C overnight. 
Additional amount of trypsin was added and incubated for 4 hours at 37 °C. Digested 
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proteins were then spun down to a clean collecting tube, 50 µl NaCl 0.5 M was added and 
spin down, acidified with trifloroacetic acid, desalted using HBL Oasis, Speed vac to dry and 
stored in -80°C until analysis. 
Liquid chromatography  
ULC/MS grade solvents were used for all chromatographic steps. Each sample was loaded 
using split-less nano-Ultra Performance Liquid Chromatography (10 kpsi nanoAcquity; 
Waters, Milford, MA, USA). The mobile phase was: A) H2O + 0.1 % formic acid and B) 
acetonitrile + 0.1 % formic acid. Desalting of the samples was performed online using a 
reversed-phase C18 trapping column (180 µm internal diameter, 20 mm length, 5 µm particle 
size; Waters). The peptides were then separated using a T3 HSS nano-column (75 µm 
internal diameter, 250 mm length, 1.8 µm particle size; Waters) at 0.35 µL/min. Peptides 
(proteomics analysis) were eluted from the column into the mass spectrometer using the 
following gradient: 4  % to 20 % B in 155 min, 20 % to 90 % B in 5 min, maintained at 95 % 
for 5 min and then back to initial conditions. 
Peptides (pull-down analysis) were eluted from the column into the mass spectrometer using 
the following gradient: 4 % to 35 % B in 105 min, 35 % to 90 % B in 5 min, maintained at 95 
% for 5 min and then back to initial conditions. 
Mass Spectrometry 
The nanoUPLC was coupled online through a nanoESI emitter (10 μm tip; New Objective; 
Woburn, MA, USA) to a quadrupole orbitrap mass spectrometer (Q Exactive HF or Q 
Exactive Plus,  Thermo Scientific) using a FlexIon nanospray apparatus (Proxeon).  
Data was acquired in DDA mode, using a Top20 method. For Q Exactive HF analysis, MS1 
resolution was set to 60,000 (at 400 m/z) and maximum injection time was set to 20 msec. 
MS2 resolution was set to 15,000 and maximum injection time of 60 msec. For Q Exactive 
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Plus analysis, MS1 resolution was set to 70,000 (at 400 m/z) and maximum injection time 
was set to 120 msec. MS2 resolution was set to 35,000 and maximum injection time of 60 
msec. 
Data processing and analysis 
Raw data was imported into the Expressionist® software (Genedata) and processed as 
described here
 
[75]. The software was used for retention time alignment and peak detection of 
precursor peptides. A master peak list was generated from all MS/MS events and sent for 
database searching using Mascot v2.5 (Matrix Sciences). For proteomics lysate analysis 
MS/MS spectra was also searched using MSGF+ (Integrative Omics, 
https://omics.pnl.gov/software/ms-gf). Data was searched against the E. coli K12 protein 
sequences as downloaded from UniprotKB (http://www.uniprot.org/), and appended with 125 
common laboratory contaminant proteins. Fixed modification was set to 
carbamidomethylation of cysteines and variable modifications were set to oxidation of 
methionines and deamidation of N or Q. Search results were then filtered using the 
PeptideProphet
 
[76] algorithm to achieve maximum false discovery rate of 1% at the protein 
level. Peptide identifications were imported back to Expressions to annotate identified peaks. 
Quantification of proteins from the peptide data was performed using an in-house script
 
[75]. 
For lysate analysis protein intensity was normalized based on the total ion current. For pull-
down experiments the data was not normalized. Protein abundance was obtained by summing 
the three most intense, unique peptides per protein. A Student’s t-Test, after logarithmic 
transformation, was used to identify significant differences across the biological replica. Fold 
changes were calculated based on the ratio of arithmetic means of the case versus control 
samples. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Purification and characterization of IMPDHs and NrdR 
Full-length guaB (Gene ID: 946985) and nrdR (Gene ID: 947437) genes were PCR amplified 
from the genome of E. coli and guaB gene (Gene ID: 880535) from P. aeruginosa. Cloned 
into a pET-21a vector, with an C-terminal hexahistidine tag. The expression and purification 
procedure for IMPDHs was the same as for ApaH, while NrdR expression was for 16 h at 16 
°C after IPTG induction and purification process the same as described above for Apa2.  
IMPDHs (11 mg/ml) were stored in 50 mM HEPES pH 7.8, 150 mM KCl and 7 mM MgCl2 
buffer and NrdR (8.9 mg/ml) in 50 mM TRIS pH 8.3, 300 mM NaCl, 5 mM DTT, 100 µM 
ZnCl2, 20 % glycerol buffer. Proteins were stored at – 20 °C. 
For assaying IMPDH’s activity 2 µM enzyme was incubated with 1 mM NAD and 2 mM 
inosine monophosphate (IMP) in reaction buffer of 50 mM HEPES pH 7.8, 150 mM KCl and 
7 mM MgCl2. The reaction was monitored by increase in absorbance at 340 nm (Synergy HT, 
BIO-TEK) in 96-well plates (655801, Greiner Bio-one). 
ELISA assays 
Binding to DNA was performed by an ELISA-like assay. The promoter region of gsk (Gene 
ID: 946584) and nrdA (Gene ID: 946612) genes were amplified from E. coli genome using 
specific primers, followed by a second PCR using a forward biotinylated primer (Table S1). 
The PCR products were purified, and the DNA concentration was determined by measuring 
A260nm (NanoDrop 2000, ThermoScientific). Streptavidin-coated plates (StreptaWell, Roche) 
were incubated for 30 min with 100 µl solutions of either biotin, biotinylated ATP or 
biotinylated Ap4A (at 2 µM), or biotinylated dsDNA (3 ng/µl). The wells were washed (50 
mM HEPES pH 7.8, 150 mM KCl, 7 mM MgCl2), and the ones coated with dsDNA were 
treated with 0.125 M NaOH (3 x 100 µl) to generate ssDNA [77]. After further washing, the 
wells were blocked with 1 % BSA. Coated wells were incubated for 1 h with 5 µM 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
ecIMPDH, paIMPDH, or NrdR in 50 mM HEPES pH 7.8, 150 mM KCl, 7 mM MgCl2, plus 
various concentrations of ATP and Ap4A as specified. The unbound proteins were washed, 
and 100 µl 1 µg/ml HRP labeled mouse antiHis-antibody (200 µg/ml, Santa Cruz 
Biotechnology) was added. Following 1 h incubation, the wells were washed, the substrate 
was added 3,3’,5,5’-tetramethybenzidine (TMB; ES001, Millipore), and OD650nm was 
monitored .The results are presented as the rate of increase in OD650nm. 
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Supporting information 
Table S1. Primers used for generation and cloning in pET_21a of LysU library. 
Table S2. Primers used for cloning. 
Tables 
Table 1. Ap4A intracellular concentrations in the generated E. coli K12 strains. Cells 
were grown in M9-Glc medium for 24 h, diluted 100-fold in fresh M9-Glc, grown and 
pelleted at the exponential phase. Measurements of Ap4A concentrations were done in 
duplicate and mean values with standard deviation are presented. 
# Strain Description 
Ap4A 
(µM) 
1 
Parental strain E. coli K12 
MG1655 
K12 (wild type) 0.2 ± 0.1 
2 
Knockout of Ap4A 
hydrolase 
K12 ΔapaH 63.6 ± 1.9 
 
Strains where apaH’s ORF was exchanged with ORFs of 
the denoted Ap4A hydrolase variants plus a TetR cassette 
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3 K12 ΔapaH::apaH Wild type E. coli ApaH 0.2 ± 0.0 
4 K12 ΔapaH::apa2 S. cerevisiae Ap4A phosphorylase < 0.02 
5 K12 ΔapaH::apaH_D7 
A computationally designed ApaH 
variant with higher thermostability 
0.1 ± 0.0 
6 
K12 ΔapaH::apaH_D7 
H120A 
An active-site mutation, H120A, 
yielding an inactive ApaH 
72.0 ± 3.5 
7 
K12 ΔapaH::apaH_D7 
H227A 
An active-site mutation, H227A, 
with > 200 fold decreased Ap4A 
hydrolase activity 
78.1 ± 19.9 
 Strains with pZA plasmid expression of LysU variants  
8 K12; pZA_LysU Wild type LysU 0.8 ± 0.1 
9 K12; pZA_InT An inactive variant of LysU 0.2 ± 0.1 
10 
K12; pZA_ 
LysU_Ap4Asynth 
A LysU variant with increased 
Ap4A synthetase activity and 
abolished aminoacylation 
0.9 ± 0.1 
11 K12 ΔapaH; pZA_LysU As # 8 at ΔapaH background 62.9 ± 12.5 
12 K12 ΔapaH; pZA_InT As # 9 at ΔapaH background 58.8 ± 10.7 
13 
K12 ΔapaH; 
pZA_LysU_Ap4Asynth 
As # 10 at ΔapaH background 59.5 ± 15.9 
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Table 2. High Ap4A levels do not cause cell death. E. coli K12 WT and ΔapaH cell pre-
cultures were adjusted to OD 0.2 and further diluted 100-fold in LB media and incubated at 
46 °C. Every hour, 250 µl aliquots of 10
-4
 dilutions of these cultures were plated on LB agar, 
and the number of colonies was counted after overnight growth at 37 °C. Experiments were 
done in duplicates and the mean values and standard deviations are presented. 
 
Time (h) Wild type (cells/ml * 10
6
) ΔapaH (cells/ml * 10
6
) 
0 1.88 ± 0.28 1.30 ± 0.14 
1 3.42 ± 0.08 1.08 ± 0.17 
2 16.08 ± 0.06 1.34 ± 0.48 
3 41.60 ± 4.63 1.54 ± 0.28 
4 54.00 ± 8.49 1.04 ± 0.28 
5 180.00 ± 33.94 0.72 ± 0.06 
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Table 3: Proteins down-regulated in E. coli K12 ΔapaH during exponential growth in 
M9-Glc. 
 
Name 
WT/ΔapaH 
ratio, (number 
of identified 
peptides) 
Notes 
50S ribosomal protein 
L31 type B, YkgM 
4-8, (3-7) 
A paralog of L31, a 50S ribosomal subunit 
protein, that lost the metal-binding "zinc 
ribbon" motif; may take over L31’s function 
at low zinc [78] 
Metal-binding protein, 
ZinT 
2-6, (4-10) 
Binds divalent metal ions (Zn
2+
, Cd
2+
, Ni
2+
) 
and is up-regulated in response to low zinc  
[79] 
High-affinity zinc uptake 
system protein, ZnuA 
4-13, (8-16) 
Zn
2+
-binding component of ABC transporter 
[80] 
Anthranilate synthase 
component 1, TrpE 
2-7, (11-21) Biosynthesis of tryptophan [81] 
Tryptophan synthase 
alpha chain, TrpA 
2-4, (9-18) Biosynthesis of tryptophan [82] 
Phospho-2-dehydro-3-
deoxyheptonate aldolase, 
AroF 
3-4, (14-21) Biosynthesis of aromatic amino acids [83] 
T-protein, TyrA 2-3, (12-24) 
Biosynthesis of aromatic amino acids 
(tyrosine and phenylalanine) [84] 
Starvation-sensing 
protein, RspA 
4-7, (2-7) 
Bifunctional dehydratase that utilizes both D-
mannonate and D-altronate as substrates [85] 
Starvation-sensing 
protein, RspB 
2-3, (3-5) 
Predicted Zn
2+
-dependent oxidoreductase, on 
the same operon with rspA [85] 
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Table 4. Putative Ap4A binding proteins identified by pull-downs. 
 
Protein name 
Enrichment in 
bioAp4A samples 
(number of 
identified peptides) 
Notes 
Inosine-5'-monophosphate 
dehydrogenase (IMPDH), GuaB 
50-120 (28-53) 
Catalyzes the first step in de novo 
guanine biosynthesis [53] 
Transcriptional repressor, NrdR 3-68, (4-9) 
Zinc-finger/ATP transcriptional 
regulatory protein, regulates the 
expression of ribonucleotide 
reductases (RNRs) [61] 
30S ribosomal protein S8, RpsH 2-6, (3-5) 
Functions in the post-transcriptional 
regulation of the ribosomal protein 
genes [86] 
DNA-binding protein, H-NS 2-12, (6-9) 
Regulates 5% of all E. coli genes and 
has a key role in bacterial chromosome 
organization [87] 
Chaperone protein, DnaK ~2, (6-64) 
The Hsp70 chaperone in E. coli. 
Contributes to control of the heat 
shock. Also involved in the initiation 
complex at the viral origin of 
replication ori-λ [88] 
DNA-binding protein HU-beta, 
HupB 
2-3, (2) 
β-subunit of HU transcriptional 
regulator, small DNA-binding protein 
that is considered a global regulatory 
protein [89] 
50S ribosomal protein L7/L12, RplL 2-4, (3-5) 50S ribosomal subunit protein [90] 
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Figure 1. Phenotypic characterization of the apaH knockout alongside the parental E. 
coli K12 strain. Cells grown to late stationary phase. This pre-culture was diluted to OD600nm 
= 0.2 and transferred at 50-fold dilution to a fresh medium. (A) LB pre-culture transferred to 
LB, growth at 37 °C. (B) M9-Glc pre-culture transferred to in LB, growth at 37 °C. (C) LB 
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pre-culture transferred to M9-Glc, growth at 37 °C. (D) M9-Glc pre-culture transferred to 
M9-Glc, growth at 37 °C. (E) Growth in LB at 46 °C. (F) Light microscopy image after 4h 
growth in LB at 46 °C. All growth experiments were done in 4 repeats and the mean OD600nm 
values with standard deviation are presented.  
 
 
 
 
 
 
Figure 2. Replacements of ApaH have no growth effect as long as Ap4A is effectively 
removed. Shown are growth curves in LB at 46 °C (A) and M9-Glc at 37 °C (B). Ap4A 
levels of these strains are provided in Table 1. Chromosomal replacements of ApaH (open 
reading frame only) with yeast Apa2, a stabilized ApaH variant (ApaH_D7), and ApaH 
mutants with impaired enzymatic activity. Growth experiments were done in 4 repeats and 
the mean OD600nm values with standard deviation are presented. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
Figure 3. Decrease of Ap4A levels below wild-type’s level has no fitness effect.  (A) 
Plasmid expression of Apa2, or its enzymatically inactive mutant (H161A), in the wild type 
strain in LB at 46 °C. (B) Plasmid expression of Apa2, or its enzymatically inactive mutant 
(H161A), in ΔapaH strain in LB at 46 °C and (C) in M9-Glc at 37 °C. (D, E) Growth 
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competitions between E. coli K12 expressing an active yeast Apa2 and the same strain with 
an inactive Apa2 control. Cells were mixed at equal ratios and this inoculate was grown over 
48 h at 37 °C in LB medium (D) and M9-Glc medium (E). The ratio of the competing strain 
(active yeast Apa2; undetectable Ap4A levels) over the control strain (inactive Apa2; WT-
like Ap4A levels) is indicated in dark red squares. These ratios are essentially identical to 
those seen in a parallel competition of a K12 strain carrying a chloramphenicol resistance 
marker with an identical strain with no such marker (black circles). All growth experiments 
were done in 3 repeats and the mean values with standard deviation are presented. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
Figure 4. Artificially induced Ap4A production has no observable phenotype. (A) Ap4A 
synthetase and aminoacylation activities of LysU evolved variants, LysU_A2 and 
LysU_Ap4Asynth, compared to wild-type LysU. Measurements were done in duplicate and 
ratio of the mean values with standard deviations are presented. (B) Induced expression of 
LysU in E. coli K12 has no growth effect, regardless if wild-type LysU is expressed, or 
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LysU-inactive (InT), or the engineered Ap4A synthase, LysU_Ap4Asynth. Shown is growth 
in M9-Glc at 37 °C; identical growth of these strains was also seen at 46 °C. (C) Growth 
effects in M9-Gl at 37 °C were observed in the ΔapaH strain and upon induction of LysU 
expression with AHT. Wild-type LysU, but not its inactivated mutant, InT, caused a lag 
phase that was further elongated by the engineered Ap4A synthetase variant 
LysU_Ap4Asynth. (D, E) Growth competitions between an E. coli K12 strain expressing the 
Ap4A producing LysU variant and a control strain expressing a LysU inactive variant over 48 
h at 37 °C in LB medium (D) and M9-Glc medium (E). The ratio of the competing strain 
(~4.5-fold higher Ap4A levels) over the control strain (WT-like Ap4A levels) is indicated in 
purple squares, and the control competition is indicated in black circles.  Growth experiments 
were done in 3 repeats and the mean values with standard deviation are presented. 
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Figure 5. Elevated Ap4A levels enable growth under Zn
2+
 deprivation. Growth of the 
parental E. coli K12 and the ΔapaH strain at 37 ºC in M9-Glc, and in same medium 
supplemented with 0.2 mM EDTA. Growth experiments were done in 3 repeats and the mean 
OD600nm values with standard deviation are presented. 
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Figure 6. The effects of ATP and Ap4A on the catalytic and regulatory activity of 
IMPDHs. (A) Binding of E. coli IMPDH (ecIMPDH) to biotinylated ATP and Ap4A was 
determined by ELISA (coating ligands onto streptavidin coated plates, and detection of His-
tagged IMPDH with anti-His antibodies). (B) The enzymatic activity of ecIMPDH in the 
presence of ATP and Ap4A. (Shown are initial rates of NAD
+
 reduction, at [IMPDH] = 2 
µM; [IMP]0 = 2 mM; [NAD
+
]0 = 1 mM.) (C) Binding of ecIMPDH to ssDNA in the presence 
of various concentrations of ATP and Ap4A. (Measured as in part A, with an immobilized 5’-
biotinylated 300 nt long ssDNA that includes the gsk gene promoter region). (D) The 
enzymatic activity of paIMPDH in the presence of varying concentrations of ATP and Ap4A 
(measured as in part B). (E) The enzymatic activity of paIMPDH in the presence of 1 mM 
ATP and different Ap4A concentrations. (F) The enzymatic activity of paIMPDH in the 
presence of 0.1 mM ATP and different Ap4A concentrations. All the measurements were 
done in 3 repeats and the mean values with standard deviation are presented. 
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Figure 7. NrdR binding of Ap4A and ATP. (A) Binding of E. coli NrdR to biotinylated 
ATP and Ap4A (determined by ELISA; as in Fig. 6A). (B) NrdR binding to the nrdA 
promoter is inhibited by both ATP and Ap4A. All the measurements were done in 3 repeats 
and the mean values with standard deviation are presented.  
 
